[Factors affecting prognosis in childhood Guillain Barré syndrome]

F Ortiz Corredor1

  • 1Instituto de Ortopedia Infantil Roosevelt, Bogota, Colombia. fortiz200@hotmail.com

Revista De Neurologia
|April 1, 2004
PubMed

Insights

Guillain Barré syndrome (GBS) in children with quadriplegia and electrical non-excitability by day 10 indicates a poor prognosis. These children experience significantly longer motor recovery times compared to those with excitable motor nerves.

Area of Science:

  • Neurology
  • Pediatrics
  • Clinical Electrophysiology

Context:

  • Guillain Barré syndrome (GBS) is a leading cause of acute flaccid paralysis in children.
  • Prognostic factors for GBS in Latin America remain underexplored.
  • This study focuses on pediatric GBS patients in a tertiary care setting.

Purpose:

  • To identify clinical and electrophysiological indicators of GBS prognosis in children.
  • To evaluate factors influencing recovery time in pediatric GBS patients.
  • To correlate early disease indicators with long-term functional outcomes.

Summary:

  • A prospective study of 67 pediatric GBS patients identified protracted plateau time, day 10 quadriplegia, and electrical non-excitability as linked to prolonged recovery.
  • Kaplan-Meier and Cox analyses revealed quadriplegia with electrical non-excitability significantly predicted longer recovery to Hughes stage III (mean 172.7 days).
  • Conversely, patients with excitable motor nerves and no quadriplegia achieved functional recovery faster (mean 39.51 days).

Impact:

  • Identifies specific clinical and electrophysiological markers for predicting GBS recovery in children.
  • Highlights the poor prognosis associated with quadriplegia and electrical non-excitability in pediatric GBS.
  • Provides valuable data for prognostic assessment and management strategies in pediatric neurology.
Abstract

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...